NCT05756309

Brief Summary

This study will verify the 1-channel patch-type ECG's arrhythmia diagnostic concordance rate and electrocardiogram measurement performance in pediatric patients by collecting ECG signals from patch-type ECG and Holter device simultaneously for data analysis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 16, 2023

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

February 13, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 6, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

2 years

First QC Date

February 13, 2023

Last Update Submit

August 6, 2024

Conditions

Keywords

ECG monitoring patchValidation of Electrocardiogram waveformValidation of heart rate accuracyValidation of arrhythmia diagnosis concordancePatients with cardiac arrhythmiaHolterWearable patch-type electrocardiograph

Outcome Measures

Primary Outcomes (2)

  • Rate of arrhythmia diagnosis between patch-type electrocardiograph and commercial Holter device measurement data by arrhythmia categories

    Rate of arrhythmia diagnosis between 24-hour patch-type electrocardiograph and commercial Holter device measurement data by arrhythmia categories(total of 19 including ventricular ectopic beat)

    Within 3 months after electrocardiogram procedure

  • Rate of ECG signal concordance between patch-type electrocardiograph and holter device

    Calculate the concordance (%) of the ECG signal by comparing and analyzing total QRS complex, total ventricular ectopic beats, total atrial ectopic beats, minimum heart rate(bpm), maximum heart rate(bpm), average heart rate(bpm) and maximum RR interval(ms)

    Within 3 months after electrocardiogram procedure

Study Arms (1)

Electrocardiogram measurements by holter device and patch-type electrocardiographic at the same time

EXPERIMENTAL

The patient is measured electrocardiogram simultaneously through a holter device and patch-type electrocardiograph

Device: Electrocardiogram measurements by holter device and patch-type electrocardiographic at the same time

Interventions

The patient is measured electrocardiogram simultaneously through a holter device and patch-type electrocardiograph

Electrocardiogram measurements by holter device and patch-type electrocardiographic at the same time

Eligibility Criteria

Age29 Days - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • More than 29 days old and less than 19 years old
  • Patients who are need regular Holter electrocardiography among outpatients or hospitalized patients at the Pediatrics, Samsung Medical Center
  • Those who gave written consent to this clinical study or obtained the written consent of the legal representative

You may not qualify if:

  • Patients who cannot give consent through the patient ownself or legal representative
  • If the researcher judges that participation in this study is inappropriate for other reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, South Korea

RECRUITING

Related Publications (7)

  • Rajbhandary PL, Nallathambi G, Selvaraj N, Tran T, Colliou O. ECG Signal Quality Assessments of a Small Bipolar Single-Lead Wearable Patch Sensor. Cardiovasc Eng Technol. 2022 Oct;13(5):783-796. doi: 10.1007/s13239-022-00617-3. Epub 2022 Mar 15.

    PMID: 35292914BACKGROUND
  • Kancharla K, Estes NAM. Mobile cardiac monitoring during the COVID-19 pandemic: Necessity is the mother of invention. J Cardiovasc Electrophysiol. 2020 Nov;31(11):2812-2813. doi: 10.1111/jce.14726. Epub 2020 Sep 3. No abstract available.

    PMID: 32852854BACKGROUND
  • Fung E, Jarvelin MR, Doshi RN, Shinbane JS, Carlson SK, Grazette LP, Chang PM, Sangha RS, Huikuri HV, Peters NS. Electrocardiographic patch devices and contemporary wireless cardiac monitoring. Front Physiol. 2015 May 27;6:149. doi: 10.3389/fphys.2015.00149. eCollection 2015.

    PMID: 26074823BACKGROUND
  • Kennedy HL. The evolution of ambulatory ECG monitoring. Prog Cardiovasc Dis. 2013 Sep-Oct;56(2):127-32. doi: 10.1016/j.pcad.2013.08.005. Epub 2013 Sep 11.

    PMID: 24215744BACKGROUND
  • Garson A Jr. Arrhythmias in pediatric patients. Med Clin North Am. 1984 Sep;68(5):1171-210. doi: 10.1016/s0025-7125(16)31091-4.

    PMID: 6492933BACKGROUND
  • Solomon MD, Yang J, Sung SH, Livingston ML, Sarlas G, Lenane JC, Go AS. Incidence and timing of potentially high-risk arrhythmias detected through long term continuous ambulatory electrocardiographic monitoring. BMC Cardiovasc Disord. 2016 Feb 17;16:35. doi: 10.1186/s12872-016-0210-x.

    PMID: 26883019BACKGROUND
  • Yenikomshian M, Jarvis J, Patton C, Yee C, Mortimer R, Birnbaum H, Topash M. Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review. Curr Med Res Opin. 2019 Oct;35(10):1659-1670. doi: 10.1080/03007995.2019.1610370. Epub 2019 May 28.

    PMID: 31045463BACKGROUND

MeSH Terms

Conditions

Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Junghwan Park

    CEO

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2023

First Posted

March 6, 2023

Study Start

January 16, 2023

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations